FindTrial
Sign In

Effect of DFDBA, Vitamin D3 Gel and its Combination on Peri- implant health

Evaluation of Dimensional Influence of DFDBA, Vitamin D3 Gel and Combination of DFDBA with Vitamin D3 Gel on Peri-Implant Tissues in Immediate Implants Placed in Maxillary Anterior Region and Its Correlation with Patient Reported Outcome Measures: A Randomised Control Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044444
Enrollment
60
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K084- Partial loss of teeth

Interventions

Intervention1: Immediate implant placement in the extraction socket: Immediate implant placement in the extraction socket with the addition of the Vitamin d 3 gel in the test group Control Interventio

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Systemically healthy patients of at least 21 years of age. 2. Patient with healthy and stable soft tissue architecture 3. Sites at which minimum torque of 35 Ncm is obtained at the time of implant insertion. 4. Co-operative, motivated and hygiene conscious patients. 5. Presence of an antagonistic tooth. 6. The absence of diastema allowing the evaluation of at least a mesial contact point. 7. Patient with tooth indicated for extraction in anterior maxilla and suitable of immediate implant placement. 8. Adequate volume of native bone to accommodate dental implants.

Exclusion criteria

Exclusion criteria: 1. General contraindications to implant surgery. 2. Smokers or patients with poor oral hygiene. 3. Patients with para-functional habits. 4. Pregnant or lactating females. 5. An acute or chronic infection at the site intended for implant placement

Design outcomes

Primary

MeasureTime frame
A] Soft Tissue Assessment: Peri-implant probing depth Mesiodistal papilla fill, color, contour, texture of peri-implant soft tissue, width of keratinised tissue, peri-implant soft tissue dehiscence, gingival thickness. B] Hard Tissue Assessment: Implant Stability Quotient, Plaque index, Modified Sulcus bleeding index, Crestal bone height (Mesial/Distal), Ridge Width. Timepoint: Baseline, 6 months,1 year and 2years—

Secondary

MeasureTime frame
Patient-reported outcomes (PROMs) achieved through VAS Score, Esthetic Score and Oral health related quality of life questionnaire.Timepoint: The PROMS will be evaluated at baseline, 1 year and 2 years—

Countries

India

Contacts

Public ContactDr Pranjali Bawankar

VSPM Dental College and Research Centre, Nagpur

Drpranjalibawankar@gmail.com09975128729

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026